DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
H••••••••• R•••••• M••••••••• L••
Private credit managerClassification probableUpper middle marketSEC registered investment adviser· Stamford, CTh••••••••.com
••• Locked
As of · identity and classification; each section below carries its own date
- Regulatory AUM
- $3.8B
- PE fund assets
- $6.0B
- PE funds
- 11
- Investments held
- 0 of 71
- Deals, last 12 months
- Not established
Form ADV
Form ADV
Form ADV
DFX transaction tape
As of · identity and classification; each section below carries its own date
Why this matters
- Control majority,minority
- Graphs 3
- Placement agents 6
Classification
How this organization is classified, and on what basisPrivate credit manager · 2 in historyShowHide
- Class
- Private credit managerprobable, confidence 70%
- Basis
- R1b: the adviser's name says 'R••••••' (credit, royalty or BDC manager), not a control buyer
- Size band
- Upper middle marketdefined by: proxy: $6.03bn Private Equity Fund GAV on the Form ADV filed 2024-03-27
Classification history (2)
- Sep 13, 2026Private credit manager (probable, 70%, cls-pe-2)R1b: the adviser's name says 'R••••••' (credit, royalty or BDC manager), not a control buyer
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 15 of 15 distinct vehicles are sworn P•••••• Equity Funds; 15 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
- Adviser type
- registered investment adviser
- Form ADV filings
- Mar 17, 2014 to Aug 17, 2026
- RAUM
- $3.8Bregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 11
- PE fund GAV, latest filing
- $6.0Breported gross assets (Form ADV), not fund size
- All private fund GAV
- $7.2Bevery private fund type, latest filing
- 2024 PE fund GAV
- $6.0Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-27, latest gav Private Equity Fund $6.0B, latest counts Private Equity Fund 11, lifetime distinct Private Equity Fund 15
- Employees
- 23
- Headquarters
- Stamford, CT
- Office address
- ••• Locked
- Business phone
- ••• Locked
Stated criteria beside observed behaviour
71 observed deals
Stated by the firm
- Sectors
- not stated or not yet read
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- majority,minority
- Thesis
- not stated or not yet read
Observed from deals on record
- roles
- unknown 71
- period
- to unknown, from unknown, undated holdings 71, dated observations 0
- window
- last unknown, first unknown
- control
- unknown 71
- companies
- 71
- geography
- investments
- 71
- seller kinds
- transactions
- 0
- cadence by year
- platform add on
- add ons 0, platforms 0, add ons per platform unknown
- sector known for
- 1
- disclosed value usd
- n 0
- sector distribution
- count 1, share 0.014, value healthcare services, examples Verastem Oncology
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 1, share 0.014, value outpatient specialty clinics, examples Verastem Oncology
71 companies on the graph (0 transactions); most in healthcare services (1); no dated observations
Funds
15 on record, 1 more on the reporting tape
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| H•• S••••••• F••• I•• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2024 first reported on Form ADV | $150M as of Mar 27, 2024 | no Form D | Unknown | |
| H•• P•••••• F••• I•• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2024 first reported on Form ADV | $100M as of Mar 27, 2024 | no Form D | Unknown | |
| H••• I••••••••• H•••••• L••• ADV: P•••••• Equity Fund | Feeder or parallel | 2023 first reported on Form ADV | $1.3B as of Mar 27, 2024 | no Form D | Early deployment | |
| H••• H••••••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $1.3B as of Mar 27, 2024 | no Form D | Early deployment | |
| H••• I••••••••• H•••••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $1.3B as of Mar 27, 2024 | no Form D | Early deployment | |
| H•• C••••• F•••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $45.8M as of Mar 27, 2024 | no Form D | Unknown | |
| H•• P•••••• F•••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2020 first reported on Form ADV | $256M as of Mar 31, 2022 | no Form D | Wound down | |
| H••••••••• R•••••• P••••••• I•• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2019 first reported on Form ADV | $1.1B as of Mar 27, 2024 | no Form D | Harvest | |
| H•• M•••• F•••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2018 first reported on Form ADV | $172M as of Mar 27, 2024 | no Form D | Mature | |
| H•• S••••••• F•••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2017 first reported on Form ADV | $409M as of Mar 31, 2022 | no Form D | Wound down | |
| H•• H••••• F•••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | 2017 first reported on Form ADV | $9.5M as of Mar 27, 2024 | no Form D | Harvest | |
| H••••••••• R•••••• P••••••• I••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | unknown | $574M as of Mar 27, 2024 | no Form D | Harvest | |
| H••• O••••••• F•••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | unknown | $282M as of Mar 31, 2023 | no Form D | Wound down | |
| H••••••••• R•••••• P••••••• I•• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | unknown | $96.4M as of Mar 31, 2023 | no Form D | Wound down | |
| H••••••••• R•••••• P•••••••• L••• ADV: P•••••• Equity Fund | buyout or unlabelled | unknown | $24.5M as of Mar 27, 2024 | no Form D | Harvest |
Gross assets by year from the annual reporting tape
These funds appear in this adviser’s Form ADV reporting. One row per fund per year (the latest filing of that year). Values are reported gross assets, not fund size.
| Fund | Type (ADV) | Years | Path | Latest reported GAV | Source |
|---|---|---|---|---|---|
| G••• I• L••• | P•••••• Equity Fund | 2026 to 2026 | $233M filed Aug 17, 2026 | reports.adviserinfo.sec.gov |
Team
7 current, 7 former
Managing partner (1)
- C••••••••• A••••• W•••• · President And Chief Financial Officer · since Dec 1, 2014 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Partner (1)
Platform (4)
- S•••••• H••••• S•••••••• · Chief Compliance Officer And Chief Patent Counsel · since Feb 1, 2012 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- T••••• K•••• C••••• · Chief Accounting Officer · since Apr 1, 1992 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- T•••••• R•••••• M••••• B••••• · General Counsel · since May 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- W••••• H• C••••• · MB, BS, BSc, MFPMChief Medical Officer · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Other (1)
- A••••• P••••• · Interview with Dr. Robert Langer, HCRx Senior Advisor · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
7 former (kept with end dates)
- G•••••• B••••• B•••• · Vice Chairman · Oct 1, 2007 to Mar 31, 2023 Inference
- T••• C••••••••• D•••• · Managing Partner · Dec 1, 2006 to Mar 27, 2018 Inference
- J••• a• U••••••• · Senior Managing Director · Jan 1, 2018 to Mar 27, 2024 Inference
- M•••••• Q•••• R•••• · Managing Director · Jan 1, 2008 to Mar 27, 2018 Inference
- P••• H••••• · Senior Managing Director · Apr 1, 2007 to Mar 31, 2023 Inference
- W••••• H• C••••• · Senior Managing Director · Jan 1, 2017 to Mar 27, 2024 Inference
- A••••• T••••• R•••••• · Chief Legal Officer · Jul 1, 2011 to Mar 31, 2023 Inference
Portfolio
71 relationships, 0 platforms, 0 add-ons
Transactions
0 on record
No transaction naming this firm has been collected yet. The deal tape is read from SEC filings and cited announcements.
Placement agents, lenders, advisers and co-investors
6 relationships
Placement agents (6)
- C••••• S••••• S••••••••• •••• L•• 8 shared · very strong · last Jan 1, 2023
- T••••••••• L•• 4 shared · strong · last Jan 1, 2019
- G••••••••• C•••••• M•••••• L•• 3 shared · strong · last Jan 1, 2017
- M••••• S•••••• 3 shared · strong · last Jan 1, 2017
- T••••••••• C••••••••• 1 shared · one time · last Jan 1, 2019
- C• P•••••• B••• 1 shared · one time · last Jan 1, 2014
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
4 most recent
- Apr 2, 2026••• Locked
- Mar 3, 2026••• Locked
- Jul 30, 2025••• Locked
- Mar 17, 2014••• Locked
Across the graphs
H••••••••• R•••••• M••••••••• L•• is the same institution as 3 records in Independent Sponsors, RIA and Wealth and Private Credit.
Independent Sponsors1RIA and Wealth1Private Credit1
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…